# Micronics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micronics

- Industry: Medical Devices & Equipment
- Headquarters: Redmond, US
- Website: www.micronics.net
- Total disclosed funding: $6M
- Latest round: Series C (Oct 16, 2008)
- Investors on record: 5

## About

Micronics is a technology firm specializing in innovative filtration and separation solutions for industries such as water treatment, chemical processing, and food and beverage manufacturing.Founded in 1996 in Redmond, US, Micronics provides filtration and separation technologies across numerous industrial sectors. The company has executed 5 deals, with its most recent being a Series C round in September 2011, where it raised USD 3.00 mn led by Southwest Michigan First Life Science Fund. The firm was founded by James Neutron, who has experience in founding other companies. Micronics was acquired by Sony Corporation in September 2011.Micronics.net specializes in providing innovative technological solutions that streamline operational processes for various industries. Their core products include advanced filtration and separation technologies designed for use in industrial applications such as water treatment, chemical processing, and food and beverage manufacturing. These technologies facilitate the efficient removal of contaminants, improving product quality and operational efficiency. The company targets a diverse client base, including large-scale manufacturers, municipal water treatment facilities, and food processing plants, primarily serving markets in North America, Europe, and parts of Asia. Each product is engineered to address specific industry challenges, enhancing sustainability and compliance with regulatory standards.The revenue model of Micronics.net revolves around B2B transactions, primarily conducted through direct partnerships with industrial clients. Transactions typically involve the sale of proprietary filtration systems and ongoing maintenance services that ensure optimal performance. Clients may engage in long-term contracts that provide access to essential support and upgrades, thereby fostering ongoing revenue streams. The company offers various pricing plans tailored to the specific needs of its clients, which may include bulk purchasing agreements for large manufacturers and subscription models for maintenance and support services. Flagship products, known for their reliability and efficiency, are positioned to meet the rigorous demands of the industries they serve, contributing to a stable revenue foundation.Micronics is currently focused on developing new filtration technologies aimed at enhancing efficiency and compliance, with anticipated product launches in 2022 and 2023. The firm is targeting expansion into European and Asian markets by 2024 to broaden its global footprint. The recent funding of USD 3.00 mn will be utilized to support research and development for these new products and to facilitate entry into these new markets.

## Funding rounds

- Series C, Oct 16, 2008, $3M — RC Capital, Ardesta, Pall Corp., Southwest Michigan First Life Science Fund, Sentron Medical
- Series B, Feb 20, 2008, $3M — RC Capital, Ardesta, Pall Corp., Sentron Medical

## Investors

- RC Capital (https://capitalatlas.ai/funds/rc-capital) — Series B, Series C
- Ardesta (https://capitalatlas.ai/funds/ardesta) — Series B, Series C
- Pall Corp. — Series B, Series C
- Sentron Medical — Series B, Series C
- Southwest Michigan First Life Science Fund (https://capitalatlas.ai/funds/southwest-michigan-first-life-science-fund) — Series C